Cargando…
SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues
SARS-CoV-2-mediated interactions with drug metabolizing enzymes and membrane transporters (DMETs) in different tissues, especially lung, the main affected organ may limit the clinical efficacy and safety profile of promising COVID-19 drugs. Herein, we investigated whether SARS-CoV-2 infection could...
Autores principales: | Nwabufo, Chukwunonso K., Hoque, Md. Tozammel, Yip, Lily, Khara, Maliha, Mubareka, Samira, Pollanen, Michael S., Bendayan, Reina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172598/ https://www.ncbi.nlm.nih.gov/pubmed/37180730 http://dx.doi.org/10.3389/fphar.2023.1124693 |
Ejemplares similares
-
Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
por: Huang, Chang, et al.
Publicado: (2023) -
Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs
por: Nwabufo, Chukwunonso K., et al.
Publicado: (2022) -
Novel localization of folate transport systems in the murine central nervous system
por: Sangha, Vishal, et al.
Publicado: (2022) -
Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
por: Omeragic, Amila, et al.
Publicado: (2020) -
Interaction between dolutegravir and folate transporters and receptor in human and rodent placenta
por: Gilmore, Julian C., et al.
Publicado: (2021)